Intellectual property, pharmaceuticals and public health : Access to drugs in developing countries

Contents:
1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha;
2. Pharmaceutical Production and Access to Essential Medicines in South Africa Heinz Klug;
3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy Gaëlle Krikorian;
4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia Tatiana Andia;
5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS
Alenka Guzmán;
6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program Matthew Flynn;
7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies Kenneth C. Shadlen;
8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience Jean-Frédéric Morin and Mélanie Bourassa Forcier;
9. Access to Indian Generic Drugs: Emerging Issues N. Lalitha;
10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China Mariko Watanabe and Luwen Shi;
11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country Samira Guennif;
12. The TRIPS Agreement and Health Innovation in Bangladesh Padmashree Gehl Sampath;
Index